The effect of SGLT2 inhibition on diabetic nephropathy, autonomous of blood glucose decrease, was investigated in diabetic eNOS knockout mice [110], while further studies in fat Zucker rats have demonstrated that diabetes enhanced RNA expression of SGLT2 and SGLT1 within the kidney [111]. The gene discussed is SLC5A2; the disease is diabetes mellitus.